Critical role of Aquaporin-1 and telocytes in infantile hemangioma response to propranolol beta blockade
- 8 February 2021
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (7)
- https://doi.org/10.1073/pnas.2018690118
Abstract
Propranolol, a nonselective β-adrenergic receptor (ADRB) antagonist, is the first-line therapy for severe infantile hemangiomas (IH). Since the incidental discovery of propranolol efficacy in IH, preclinical and clinical investigations have shown evidence of adjuvant propranolol response in some malignant tumors. However, the mechanism for propranolol antitumor effect is still largely unknown, owing to the absence of a tumor model responsive to propranolol at nontoxic concentrations. Immunodeficient mice engrafted with different human tumor cell lines were treated with anti-VEGF bevacizumab to create a model sensitive to propranolol. Proteomics analysis was used to reveal propranolol-mediated protein alteration correlating with tumor growth inhibition, and Aquaporin-1 (AQP1), a water channel modulated in tumor cell migration and invasion, was identified. IH tissues and cells were then functionally investigated. Our functional protein association networks analysis and knockdown of ADRB2 and AQP1 indicated that propranolol treatment and AQP1 down-regulation trigger the same pathway, suggesting that AQP1 is a major driver of beta-blocker antitumor response. Examining AQP1 in human hemangioma samples, we found it exclusively in a perivascular layer, so far unrecognized in IH, made of telocytes (TCs). Functional in vitro studies showed that AQP1-positive TCs play a critical role in IH response to propranolol and that modulation of AQP1 in IH-TC by propranolol or shAQP1 decreases capillary-like tube formation in a Matrigel-based angiogenesis assay. We conclude that IH sensitivity to propranolol may rely, at least in part, on a cross talk between lesional vascular cells and stromal TCs. Significance Although a role for β-adrenergic receptor (ADRB) in cancer progression was suggested a long time ago, our serendipitous observation of the propranolol efficacy in treating infantile hemangioma (IH) has driven attention in exploring the antitumor properties of β-blockers. We identified Aquaporine-1 (AQP1) as a player in antitumor propranolol response and as a histological marker of IH vascular structures including telocytes, which are dendritic cells that form a distinctive peripheral layer in IH. We conclude that IH sensitivity to propranolol may rely, at least in part, on a cross talk between lesional vascular cells and stromal telocytes.Keywords
Funding Information
- Agence Nationale de la Recherche (ANR-12-BSV1-0021-01)
- Agence Nationale de la Recherche (ANR-12-BSV1-0021-01)
- Agence Nationale de la Recherche (ANR-10-INBS-04)
This publication has 77 references indexed in Scilit:
- E-Selectin Mediates Stem Cell Adhesion and Formation of Blood Vessels in a Murine Model of Infantile HemangiomaThe American Journal of Pathology, 2012
- Carbonic Anhydrase IX Promotes Tumor Growth and NecrosisIn Vivoand Inhibition Enhances Anti-VEGF TherapyClinical Cancer Research, 2012
- Low dose of propranolol down‐modulates bone resorption by inhibiting inflammation and osteoclast differentiationBritish Journal of Pharmacology, 2012
- Isolation, characterization, and in vitro propagation of infantile hemangioma stem cells and an in vivo mouse modelJournal of Hematology & Oncology, 2011
- Aquaporin-1 Promotes Angiogenesis, Fibrosis, and Portal Hypertension Through Mechanisms Dependent on Osmotically Sensitive MicroRNAsThe American Journal of Pathology, 2011
- Infantile Hemangioma--Mechanism(s) of Drug Action on a Vascular TumorCold Spring Harbor Perspectives in Medicine, 2011
- AQP1 Is Not Only a Water Channel: It Contributes to Cell Migration through Lin7/Beta-CateninPLOS ONE, 2009
- Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibitionMolecular Cancer Therapeutics, 2009
- In Vitro Sensitivity of Leukemia Cells to PropranololJournal of Clinical Medicine Research, 2009
- Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient miceJCI Insight, 2008